Chargement en cours...
Erlotinib induced ectropion following papulopustular rash
BACKGROUND: Erlotinib is a targeted anti-cancer drug which acts through the inhibition of epidermal growth factor receptor (EGFR). MAIN OBSERVATIONS: A 79-year-old developed bilateral ectropion after he received erlotinib treatment for lung adenocarcinoma. The ectropion completely resolved with symp...
Enregistré dans:
| Publié dans: | J Dermatol Case Rep |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Specjalisci Dermatolodzy
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4517803/ https://ncbi.nlm.nih.gov/pubmed/26236413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3315/jdcr.2015.1203 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|